QUANTITATIVE STUDY OF MAMMOGRAMS PERFORMED IN BRAZIL BETWEEN 2010 AND 2014

Luis Mário Mendes de Medeiros, Nathália Ramos Lopes, Bráulio Brandão Rodrigues, Clara Braga dos Santos Azevedo, Daniela Cristina Tiago, Lara Cristina Rocha Alvarenga, Luiza Ferreira Rocha, Denis Masashi Sugita

Institution: Centro Universitário de Anápolis – UniEVANGÉLICA

Objective: Compare the performance of mammography in Brazil between 2010 and 2014. Methodology: This is a quantitative study, population-based, with cross-sectional design. The data were of secondary origin, extracted from SISMAMA. There were compared four parameters: year, region, recommendation and having done a previous clinical examination. Results: In Brazil, the amount of screening mammograms performed outweigh the diagnostic ones by almost thirty-two times (32) and the year of biggest achievement of mammograms was 2012 with 26.50%. During the years analyzed, there was a decrease in the performance of mammograms, being that in 2010 amounted to 19.90% and in 2014, 11.90%. Most women have made previous clinical examination, with 77.77% of the cases, and 22.22% had never been examined. Among the medical recommendations for performing the radiological examination, mammography in two years reaches 84.11%, followed by complementation with USG, representing 10.87%. Further on comes the radiological control in 6 months, with 1.96%. The decreasing order of regions of Brazil that perform mammography is: Southeast, Northeast, South, Midwest and North. Conclusion: They are still performed many mammograms in Brazil, mostly concentrated in the Southeast, where the population is greater. It is also clear the greater amount of tracking mammograms, showing the concern of the risk population with cancer, however, from 2010 to 2014, it was found a drop in mammograms numbers. Another important factor is evidence of awareness that most women have made previous and few are newcomers in the exam. Medical recommendations for examination are generally mammogram in two years. Key word: breast cancer.

Return